TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33599340

Group type: EXPERIMENTAL
Intervention: Bilberry supplementation (1.4 g/day of extract) for 4 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 32107374

Group type: EXPERIMENTAL
Intervention: Risk-adjusted therapy for standard risk patients
Number of subjects: 1138

Group type: EXPERIMENTAL
Intervention: Risk-adjusted therapy for high risk patients
Number of subjects: 1138

Group type: EXPERIMENTAL
Intervention: Risk-adjusted therapy for extremely high risk patients
Number of subjects: 1138

Group type: EXPERIMENTAL
Intervention: NCI risk classification for standard risk patients
Number of subjects: 1138

Group type: EXPERIMENTAL
Intervention: NCI risk classification for high risk patients
Number of subjects: 1138

Group type: COMPARATOR
Intervention: Comparison to previous trial ALL-97 for NCI-SR patients
Number of subjects: 1138

Group type: EXPERIMENTAL
Intervention: CNS relapse rates
Number of subjects: 1138
Study: 36282170

Group type: EXPERIMENTAL
Intervention: 15 mg/kg intravenous tranexamic acid (TXA) administered 15 min before incision in 100 cc of saline
Number of subjects: 102

Group type: COMPARATOR
Intervention: Isotonic saline (control group)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: 15 mg/kg intravenous tranexamic acid (TXA)
Number of subjects: 102
Study: 32915346

Group type: EXPERIMENTAL
Intervention: Side-port endodontic needles (NI) without agitation
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Sonic activation using EDDY
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Sonic activation using EndoActivator (EA)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Passive ultrasonic irrigation (PUI)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control group (NI)
Number of subjects: 160
Study: 33109037

Group type: EXPERIMENTAL
Intervention: Desloratadine tablet (5mg)
Number of subjects: 56

Group type: COMPARATOR
Intervention: AERIUS (5mg)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: CYP2C8 and UGT2B10 genotypes
Number of subjects: 56
Study: 36181017

Group type: EXPERIMENTAL
Intervention: Arthroscopic cartilage regeneration facilitating procedure (ACRFP)
Number of subjects: 411
Study: 33620662

Group type: EXPERIMENTAL
Intervention: Parenting Mindfully (PM) intervention
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Parenting Mindfully (PM) intervention (secondary analysis)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Brief parent education (PE) control group
Number of subjects: 96
Study: 35365713

Group type: EXPERIMENTAL
Intervention: Antibiotic pretreatment
Number of subjects: 22

Group type: COMPARATOR
Intervention: No antibiotic pretreatment (Control)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Capsules (maintenance dose delivery)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Enema (maintenance dose delivery)
Number of subjects: 22
Study: 32249726

Group type: EXPERIMENTAL
Intervention: Childhood ADHD
Number of subjects: 8310

Group type: EXPERIMENTAL
Intervention: ADHD genetic liability
Number of subjects: 8310
Study: 32316561

Group type: EXPERIMENTAL
Intervention: Time-Restricted Feeding (TRF)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Normal Diet (ND)
Number of subjects: 26
Study: 35370419

Group type: EXPERIMENTAL
Intervention: Retrolaminar block (RLB)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Erector spinae plane block (ESPB)
Number of subjects: 0
Study: 33025323

Group type: EXPERIMENTAL
Intervention: CARDEAN
Number of subjects: 76
Study: 33739473

Group type: EXPERIMENTAL
Intervention: Cardiac Care Bridge (CCB) program
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Involvement of (in)formal caregivers
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: CCB caregivers
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Empowerment of patients and informal caregivers
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Recognition of early signs of deterioration
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Understanding of patients' care needs and expectations
Number of subjects: 18
Study: 33650840

Group type: EXPERIMENTAL
Intervention: Manual therapy and proprioceptive neuromuscular facilitation (PNF)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Traditional kinesiotherapy
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: All groups (including manual therapy, PNF, combined therapy, and traditional kinesiotherapy)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Manual therapy and PNF
Number of subjects: 200
Study: 33270062

Group type: EXPERIMENTAL
Intervention: PEEK abutment with LD crown
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: PEEK abutment with TZ crown
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: YZ abutment with TZ crown
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: YZ abutment with LD crown
Number of subjects: 40
Study: 36450787

Group type: EXPERIMENTAL
Intervention: Aluminum oxide flexible disks (Al2O3‐Disks)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Silicon carbide polyester strips (SIC‐Strips)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Negative control (NC)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: All groups (including NC)
Number of subjects: 75
Study: 33435909

Group type: EXPERIMENTAL
Intervention: nab‐paclitaxel combined with S‐1 (AS)
Number of subjects: 616

Group type: COMPARATOR
Intervention: oxaliplatin combined with capecitabine (XELOX)
Number of subjects: 616
Study: 35772462

Group type: EXPERIMENTAL
Intervention: Nivolumab plus cabozantinib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sunitinib
Number of subjects: 0
Study: 33866489

Group type: EXPERIMENTAL
Intervention: MI-consistent language
Number of subjects: 87

Group type: COMPARATOR
Intervention: MI-inconsistent language
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Teacher factors (age, efficacy, burnout, classroom organization)
Number of subjects: 87
Study: 33681652

Group type: EXPERIMENTAL
Intervention: Perampanel (2–12 mg/day)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128
Study: 33130482

Group type: EXPERIMENTAL
Intervention: Evinacumab SC 300 mg single dose
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Evinacumab SC 300 mg once weekly for eight doses
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Evinacumab IV 5 mg/kg once every 4 weeks for two doses
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Evinacumab IV 15 mg/kg once every 4 weeks for two doses
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Evinacumab (IV and SC)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study: 36353577

Group type: EXPERIMENTAL
Intervention: Umbilical cord blood infusion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32719487

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 36840609

Group type: EXPERIMENTAL
Intervention: PACE Steps to Success program
Number of subjects: 4
Study: 33410493

Group type: EXPERIMENTAL
Intervention: Physiotherapist-led exercise intervention
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: US-guided subacromial corticosteroid injection
Number of subjects: 256

Group type: COMPARATOR
Intervention: Standard advice and exercise leaflet
Number of subjects: 256

Group type: COMPARATOR
Intervention: Unguided injection
Number of subjects: 256
Study: 616787743

Group type: EXPERIMENTAL
Intervention: Computer classes and games in virtual reality environment
Number of subjects: 0
Study: 34791941

Group type: EXPERIMENTAL
Intervention: Rivaroxaban 15 mg daily
Number of subjects: 718

Group type: COMPARATOR
Intervention: Aspirin 100 mg daily
Number of subjects: 718
Study: 34628736

Group type: EXPERIMENTAL
Intervention: Motor imagery acupuncture
Number of subjects: 64

Group type: COMPARATOR
Intervention: Acupuncture plus motor imagery therapy at affected lower limb
Number of subjects: 64
Study: 32785872

Group type: EXPERIMENTAL
Intervention: TINAD program
Number of subjects: 576
Study: 33556601

Group type: EXPERIMENTAL
Intervention: Clipping for unruptured MCA aneurysms
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Coiling for unruptured MCA aneurysms
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Surgical management for ruptured MCA aneurysms
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Endovascular management for ruptured MCA aneurysms
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Clipping for unruptured MCA aneurysms (1-year imaging results)
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Coiling for unruptured MCA aneurysms (1-year imaging results)
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Clipping for ruptured MCA aneurysms (1-year imaging results)
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Coiling for ruptured MCA aneurysms (1-year imaging results)
Number of subjects: 171
Study: 36074617

Group type: EXPERIMENTAL
Intervention: Cognitive therapy (CT)
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Behavior therapy (BT)
Number of subjects: 219

Group type: COMPARATOR
Intervention: Wait-list (WL)
Number of subjects: 219
Study: 34271135

Group type: EXPERIMENTAL
Intervention: Multidimensional program including home-based standing exercises, health education, and telephone support for 16 weeks
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group received orientation regarding the harmful effects of a sedentary lifestyle
Number of subjects: 43
Study: 36103390

Group type: EXPERIMENTAL
Intervention: 20 μg vaccine SCoK
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 40 μg vaccine SCoK
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33960007

Group type: EXPERIMENTAL
Intervention: 4-week vegan diet
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 33256795

Group type: EXPERIMENTAL
Intervention: Curcumin and zinc co-supplementation
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study: 35271466

Group type: EXPERIMENTAL
Intervention: Laparoscopic methods (TAPP)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Modified Lichtenstein technique
Number of subjects: 82
Study: 34132694

Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass (RYGB)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Sleeve gastrectomy (SG)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Intensive medical therapy (IMT)
Number of subjects: 104

Group type: COMPARATOR
Intervention: RYGB vs IMT
Number of subjects: 104

Group type: COMPARATOR
Intervention: SG vs IMT
Number of subjects: 104
Study: 32682995

Group type: EXPERIMENTAL
Intervention: Narrative + AVG
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: AVG Only
Number of subjects: 210

Group type: COMPARATOR
Intervention: Control
Number of subjects: 210
Study: 36394217

Group type: EXPERIMENTAL
Intervention: Complex decongestive therapy (CDT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (individuals without lymphedema)
Number of subjects: 0
Study: 32471645

Group type: EXPERIMENTAL
Intervention: Zymomonas mobilis fermented broth once a day
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Zymomonas mobilis fermented broth twice a day
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Cell-free fermented broth once daily
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo (saline once daily)
Number of subjects: 13
Study: 35339765

Group type: EXPERIMENTAL
Intervention: Healthy Schools Healthy Students intervention
Number of subjects: 20
Study: 33958424

Group type: EXPERIMENTAL
Intervention: CHW + PL intervention
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: CHW-only intervention
Number of subjects: 222

Group type: COMPARATOR
Intervention: EUC intervention
Number of subjects: 222
Study: 34057705

Group type: EXPERIMENTAL
Intervention: 3 g/day green cardamom
Number of subjects: 194

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 194
Study: 34525492

Group type: EXPERIMENTAL
Intervention: Topical tranexamic acid after microneedling (TA + microneedling), every other week
Number of subjects: 50

Group type: COMPARATOR
Intervention: Topical 4% hydroquinone (HQ), nightly application
Number of subjects: 50
Study: 34612601

Group type: EXPERIMENTAL
Intervention: Same-day initiation (SDI) of antiretroviral therapy (ART)
Number of subjects: 1193

Group type: COMPARATOR
Intervention: Standard of care initiation procedures
Number of subjects: 1193
Study: 34237025

Group type: EXPERIMENTAL
Intervention: Qigong (QG) group (n = 34) performing Qigong exercises
Number of subjects: 104

Group type: COMPARATOR
Intervention: TV documentary (TVD) group (n = 34) watching a TV documentary
Number of subjects: 104

Group type: COMPARATOR
Intervention: Typical school duties (TSD) group (n = 36) performing regular school duties
Number of subjects: 104
Study: 32817068

Group type: EXPERIMENTAL
Intervention: Ramucirumab 8 mg/kg every 2 weeks
Number of subjects: 542

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 542
Study: 35333210

Group type: EXPERIMENTAL
Intervention: Bicep curls (4 sets of 10RM)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Leg extensions (4 sets of 10RM)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Recovery period (4, 24, or 48 hours)
Number of subjects: 28
Study: 34585336

Group type: EXPERIMENTAL
Intervention: HRank helmet
Number of subjects: 116

Group type: COMPARATOR
Intervention: LRank helmet
Number of subjects: 116

Group type: COMPARATOR
Intervention: Comparison between HRank and LRank helmets
Number of subjects: 116
Study: 34252289

Group type: EXPERIMENTAL
Intervention: 0.6 mg dasiglucagon
Number of subjects: 112

Group type: COMPARATOR
Intervention: 1.0 mg recombinant glucagon (GlucaGen®)
Number of subjects: 112
Study: 32091401

Group type: EXPERIMENTAL
Intervention: Bioresorbable vascular scaffolds (BVS)
Number of subjects: 113
Study: 35955124

Group type: EXPERIMENTAL
Intervention: School-based smoking prevention program (four classes on smoking and secondhand smoke prevention)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Scheduled school activities (control group)
Number of subjects: 0
Study: 33523189

Group type: EXPERIMENTAL
Intervention: FCHV-delivered intervention (home visits 3 times a year for health promotion counseling and blood glucose monitoring)
Number of subjects: 244

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: FCHV-delivered intervention
Number of subjects: 244
Study: 35556864

Group type: EXPERIMENTAL
Intervention: Competence‐based heterogeneous (CBH) student group formation and reciprocal peer teaching (RPT)
Number of subjects: 100
Study: 33867169

Group type: EXPERIMENTAL
Intervention: Trauma simulations
Number of subjects: 49
Study: 35413931

Group type: EXPERIMENTAL
Intervention: Training with visual feedback on both force direction and magnitude
Number of subjects: 0

Group type: COMPARATOR
Intervention: Training with visual feedback on force magnitude only (Control)
Number of subjects: 0
Study: 32727732

Group type: EXPERIMENTAL
Intervention: Free glasses and a teacher incentive (tablet computer if ≥80% of children given glasses were wearing them on un‐announced examination)
Number of subjects: 728

Group type: COMPARATOR
Intervention: Glasses prescription and letter to parents
Number of subjects: 728
Study: 32213826

Group type: EXPERIMENTAL
Intervention: High-dose vitamin D
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 33426938

Group type: EXPERIMENTAL
Intervention: Active fixation bipolar left ventricular lead
Number of subjects: 62

Group type: COMPARATOR
Intervention: Quadripolar passive fixation LV lead
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 62
Study: 36367720

Group type: EXPERIMENTAL
Intervention: Extended run-in varenicline treatment (4 weeks before quitting)
Number of subjects: 320

Group type: COMPARATOR
Intervention: Standard run-in group (3 weeks of placebo followed by 1 week of varenicline)
Number of subjects: 320
Study: 33587122

Group type: EXPERIMENTAL
Intervention: 4CMenB vaccine
Number of subjects: 30522

Group type: COMPARATOR
Intervention: Control (no vaccination in 2018)
Number of subjects: 30522
Study: 32351612

Group type: EXPERIMENTAL
Intervention: Deep learning applied on MORE homomorphic encrypted data
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Model trained on encrypted data for WBC hemodynamic model
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Privacy-preserving deep learning methods
Number of subjects: 0
Study: 35331787

Group type: EXPERIMENTAL
Intervention: Parent dietary role modeling of fruit intake at meals
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Parent dietary role modeling of fruit as a snack
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Parent fast food intake
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Child diet quality indicators (HEI-2015 total scores, FV intake, SSB intake)
Number of subjects: 114
Study: 32472263

Group type: EXPERIMENTAL
Intervention: HydroSet bone substitute
Number of subjects: 0

Group type: COMPARATOR
Intervention: No graft
Number of subjects: 0
Study: 35026536

Group type: EXPERIMENTAL
Intervention: Eating 4 Two trial
Number of subjects: 5
Study: 34905884

Group type: EXPERIMENTAL
Intervention: Computer Assisted Surgery (CAS)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Personal Specific Instrumentation (PSI)
Number of subjects: 80
Study: 36186646

Group type: EXPERIMENTAL
Intervention: 7-week therapeutic exercise program (7 × 60-min weekly sessions, supplemented by a home-based program 2-days/week)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 7-week therapeutic exercise program
Number of subjects: 21
Study: 35800080

Group type: EXPERIMENTAL
Intervention: Balance It
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Bubble Pop
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Scoop'd
Number of subjects: 30
Study: 32035749

Group type: EXPERIMENTAL
Intervention: Low-target mean arterial pressure (MAP) of 40 to 50 mmHg
Number of subjects: 143

Group type: COMPARATOR
Intervention: High-target mean arterial pressure (MAP) of 70 to 80 mmHg
Number of subjects: 143
Study: 34342754

Group type: EXPERIMENTAL
Intervention: Self-administered gut-directed hypnosis intervention (7 bi-weekly audio sessions over 3 months)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Self-administered gut-directed hypnosis intervention
Number of subjects: 23
Study: 35672003

Group type: EXPERIMENTAL
Intervention: KARLOTTA app
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no app)
Number of subjects: 30
Study: 36410812

Group type: EXPERIMENTAL
Intervention: Encorafenib with cetuximab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cetuximab with FOLFIRI or irinotecan
Number of subjects: 0

Group type: COMPARATOR
Intervention: FOLFIRI alone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bevacizumab with FOLFIRI
Number of subjects: 0
Study: 34521576

Group type: EXPERIMENTAL
Intervention: Peer-led theory-based oral health intervention
Number of subjects: 1184

Group type: COMPARATOR
Intervention: Control group (booklets for oral health promotion)
Number of subjects: 1184
Study: 34338703

Group type: EXPERIMENTAL
Intervention: Co-supplementation of Camelina sativa oil (CSO) and resistant dextrin
Number of subjects: 44
Study: 33131932

Group type: COMPARATOR
Intervention: Post F-subunit vaccine
Number of subjects: 4
Study: 33766681

Group type: EXPERIMENTAL
Intervention: Ondansetron (8mg)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 144
Study: 33007285

Group type: EXPERIMENTAL
Intervention: Intravenous antibiotics (ceftazidime and tobramycin for 14 days combined with inhaled colistimethate sodium for 12 weeks)
Number of subjects: 286

Group type: COMPARATOR
Intervention: Oral antibiotics (ciprofloxacin for 12 weeks combined with inhaled colistimethate sodium for 12 weeks)
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: Intravenous antibiotics
Number of subjects: 286

Group type: COMPARATOR
Intervention: Oral antibiotics
Number of subjects: 286
Study: 35476700

Group type: EXPERIMENTAL
Intervention: Neoantigen-based dendritic cell vaccination and neoantigen-activated T-cell therapy
Number of subjects: 10
Study: 32696128

Group type: EXPERIMENTAL
Intervention: LI-ESWT (1 session/week for 4 weeks, 5000 shocks/session, 0.09 mJ/mm2 energy density)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: LI-ESWT
Number of subjects: 76
Study: 35945992

Group type: EXPERIMENTAL
Intervention: Opioid-Free Anesthesia (OFA) with dexmedetomidine and lidocaine
Number of subjects: 75

Group type: COMPARATOR
Intervention: Remifentanil-based anesthesia (RA)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Opioid-Free Anesthesia (OFA)
Number of subjects: 75
Study: 32497042

Group type: EXPERIMENTAL
Intervention: Hookworm infection
Number of subjects: 792

Group type: EXPERIMENTAL
Intervention: Strongyloides stercoralis infection
Number of subjects: 792

Group type: EXPERIMENTAL
Intervention: Co-infection with hookworm and S. stercoralis
Number of subjects: 792

Group type: EXPERIMENTAL
Intervention: Age association with hookworm infection
Number of subjects: 792

Group type: EXPERIMENTAL
Intervention: Age association with S. stercoralis infection
Number of subjects: 792
Study: 35099230

Group type: EXPERIMENTAL
Intervention: Modular Anxiety Skills Training (MAST-V); 6 sessions of 30 minutes each
Number of subjects: 6
Study: 33530392

Group type: EXPERIMENTAL
Intervention: Projective Linear Reconstruction (PLR) algorithm
Number of subjects: 0
Study: 35854636

Group type: EXPERIMENTAL
Intervention: Passive Leg Raising (PLR)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Head-Down Tilt (HDT)
Number of subjects: 10
Study: 34836350

Group type: EXPERIMENTAL
Intervention: Glucose (1 g/kg BM)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Fructose (1 g/kg BM)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Glucose and Fructose (0.5 g/kg BM)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Sucralose (0.2 g)
Number of subjects: 15

Group type: COMPARATOR
Intervention: All conditions vs Sucralose
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Glucose vs Fructose
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Glucose vs Glucose and Fructose
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Blood lactate increase in Glucose
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Blood lactate increase in Fructose
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Blood lactate increase in Glucose and Fructose
Number of subjects: 15

Group type: COMPARATOR
Intervention: Insulin levels in all conditions vs Sucralose
Number of subjects: 15